Mar 21 |
Lyra Therapeutics reports Q4 results
|
Mar 21 |
Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
|
Mar 8 |
Here's Why Momentum in Lyra Therapeutics, Inc. (LYRA) Should Keep going
|
Mar 1 |
Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
Mar 1 |
Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics
|
Feb 29 |
5 Small Drug Stocks to Buy From a Rebounding Industry
|
Feb 26 |
Strength Seen in Lyra Therapeutics, Inc. (LYRA): Can Its 6.9% Jump Turn into More Strength?
|
Feb 21 |
Here's What Could Help Lyra Therapeutics, Inc. (LYRA) Maintain Its Recent Price Strength
|
Jan 17 |
What Makes Lyra Therapeutics, Inc. (LYRA) a Good Fit for 'Trend Investing'
|
Jan 2 |
Lyra Therapeutics: A Risk Assessment
|